Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07471607) titled 'Safety and Effectiveness of Overripe Banana Powder Added to Diabetic Formulas in Type 2 Diabetes' on March 6.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Outcomes Assessor).
Primary Sponsor: Universiti Sains Malaysia
Condition:
Type 2 Diabetes
Metabolic Disorders
Intervention:
Dietary Supplement: Overripe Banana Powder Formulation
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: March 1, 2025
Target Sample Size: 60
Countries of Recruitment:
Malaysia
To know more, visit htt...